Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Exercícios de lição de casa de realidade virtual para tratamento seletivo de mutismo

28 de setembro de 2026 atualizado por: Luuk Stapersma

The Effect of Virtual Reality Homework Exercises as an Add-On to Behavioral Therapy for Children With Selective Mutism

Selective mustism (SM) is an anxiety disorder that manifests in childhood. Children with Children with SM do not speak in certain social situations where this is expected of them. For example, a child may talk at home, but is afraid to speak at school. The goal of this clinical trial is to determine the efficacy of behavioral therapy for children with selective mutism (SM) combined with virtual reality (VR) homework exercises. Virtual Reality Exposure is an effective treatment for adults with anxiety disorders.

The main questions to answer are:

  • Is behavioral therapy combined with VR homework exercises effective in the treatment of SM?
  • Which familial factors contribute to a positive treatment outcome and homework adherence?

A single-case experimental design (SCED) will be used to evaluate the efficacy of the treatment. The child's speaking behavior at baseline will be compared to the child's speaking behavior in the different phases of the intervention.

Participants will:

  • Follow individual therapy sessions at school.
  • Practice with the VR homework exercises at least once a week.
  • Parents and teachers will evaluate the child's speaking behavior.

Visão geral do estudo

Descrição detalhada

The treatment in this study consists of behavioral therapy for SM (with the protocol 'Talking at school, a matter of doing') with the addition of the VR homework exercises. The protocol consists of 10 steps that help the child to gain confidence while speaking at school. The individual therapy sessions are provided at school. For every step of the protocol there are VR homework exercises available. Families receive a VR headset for the duration of the study. Parents are instructed to work on the VR homework exercises at least once a week and encouraged to work on the VR homework exercises several times a week. On average, treatment is approximately 25 weeks.

Tipo de estudo

Intervencional

Inscrição (Estimado)

15

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • North Holland
      • Amsterdam, North Holland, Holanda, 1076 EC
        • Recrutamento
        • Levvel
        • Contato:

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

4 anos a 13 anos (Filho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • The child meets the DSM-5 criteria for SM (as a primary classification).
  • The child is attending primary school.
  • Referred to an academic center for Child and Adolescent Psychiatry (Levvel) for diagnosis and treatment of SM
  • Psychiatric comorbidity is permitted, given that SM is the primary treatment target.
  • Medication use is permitted, if stable for at least 4 weeks prior to the start of treatment.

Exclusion Criteria:

  • No participating parents.
  • Parents do not have sufficient mastery of the Dutch language.
  • Parents or child have an estimated IQ below 75.
  • The child needs inpatient treatment.
  • Children with a (medical) condition that is a contraindication for using a VR headset (epilepsy, claustrophobia, facial condition, sensitive vestibular system, panic attacks)
  • Parents receiving parental guidance which is not part of the standard treatment program.
  • Children that have received protocolled behavior therapy for SM in the past 12 months.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Intervention

Behavioral: 'Speaking at school, a matter of doing' combined with VR homework exercises

The treatment in this study consists of behavioral therapy for selective mutism (with the protocol 'Speaking at school, a matter of doing') with the addition of the VR homework exercises. The protocol consists of 10 steps that help the child to gain confidence while speaking at school. For every treatment step there are VR homework exercises available. Families receive a VR headset for the duration of the study. Parents are instructed to work on the VR homework exercises at least once a week and encouraged to work on the VR homework exercises several times a week.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
SM symptoms (frequent measurement)
Prazo: During the baseline period (2 weeks), during the intervention phase (up to 1 year) and during follow-up (3 months after end of intervention phase), three times a week

Both parents and teachers are asked to report on SM symptoms. This is done by answering 9 yes/no questions on the child's speaking behavior and communication, including non-verbal communication, making sounds and conversing with others (more yes indicates more speaking behavior). The short assessment is specifically designed for this study in collaboration with experienced SM therapists and a statistician, specialized in SCED's.

During the baseline period (2 weeks), during the intervention phase (up to 1 year) and during follow-up (3 months after end of intervention phase), three times a week
SM symptoms (SMQ-NL)
Prazo: Baseline (2 weeks), start first phase of intervention (up to 4 months), start second phase of intervention (up to 4 months), start training phase, immediately after intervention (up to 4 months), at follow-up (3 months after end of intervention)

Evaluated by parents. The SMQ consists of 23 questions that are scored on a 4-point Likert scale ranging from "always" to "never." The symptom subscale consists of 17 questions (0-68; higher scores indicate more SM symptoms), that assess the severity of the symptoms across different situations (family, school and public situations). The second subscale indicates to what extend a child experiences problems due to not speaking in certain situations.

Baseline (2 weeks), start first phase of intervention (up to 4 months), start second phase of intervention (up to 4 months), start training phase, immediately after intervention (up to 4 months), at follow-up (3 months after end of intervention)
SM symptoms (Social context of speaking)
Prazo: Baseline (2 weeks), start first phase of intervention (up to 4 months), start second phase of intervention (up to 4 months), start training phase (up to 4 months), immediately after intervention, at follow-up (3 months after end of intervention)

The questionnaire consists of 16 questions assessing (0-64; higher scores indicate less SM symptoms) the social context of speaking assesses the severity of symptoms at school across different social situations (e.g. their own teacher, another teacher, in the classroom or in the presence of peers), speaking behaviour (e.g. whispering and functional speech) and its interference at school. Teachers are asked to evaluate how often child is showing different speaking behaviours and in which social context on a 4-point Likert scale. The questionnaire includes 8 questions that are based on the School Speech Questionnaire (SSQ). For the purpose of our study, the SSQ does not provide enough detail on the child's speaking behaviour, for that reason 8 more questions were included.

Baseline (2 weeks), start first phase of intervention (up to 4 months), start second phase of intervention (up to 4 months), start training phase (up to 4 months), immediately after intervention, at follow-up (3 months after end of intervention)

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
VR data
Prazo: During intervention phase (up to 1 year; every time child uses the VR homework exercises at home)

Each parent has a unique ID to sign-in to a web-based application that is used to guide the child through the virtual school. Parents will indicate that when the next exercise is presented. These responses are saved. Every time the parent signs in, the total time and the time spent playing the different games will be automatically stored on a secured database. This will be recorded in seconds.

During intervention phase (up to 1 year; every time child uses the VR homework exercises at home)
VR completion
Prazo: During the intervention phase (once a week, up to 1 year)

Parents are asked to track the time they spend working on the VR homework exercises on a VR tracking sheet on a weekly basis. They are asked to fill out how long and which days they practiced. The number of days practiced will be divided by the total number of days in the week. This yields a percentage of VR completion per week.

During the intervention phase (once a week, up to 1 year)
VR immersion
Prazo: During the intervention phase (once a month, up to 1 year)

Specifically for this study three questions were designed to measure the level of immersion children experience while practicing with the VR. Children are asked to rate their immersive experience on 4-point Likert scale ranging from strongly disagree to strongly agree.

During the intervention phase (once a month, up to 1 year)
Structured Clinical Interview for DSM-5 Junior (SCID-5-Junior)
Prazo: Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)

Semi-structured interview for children and adolescents between 8 -18. The interview is suitable for both children and their parents. The SCID-5 Junior consists of 17 modules to classify DSM-5 disorders. The SCID-5 Junior is used in standard clinical care, to check for additional anxiety disorders and disorders that might look like SM. The SCID-5 Junior will be administered in the same manner as in regular clinical care, meaning that parents only report on the modules: anxiety, autism and obsessive-compulsive behavior, unless there are indications that suggest the presence of another co-morbid disorder.

Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)
Fear Survey Schedule for Children - Revised (FSSC-R or in Dutch VAK 4-12)
Prazo: Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)

The FSSC-R / VAK 4-12 is a self-report questionnaire that consists of 80 items (0-240; higher scores indicate more anxiety symptoms). The items are descriptions of objects or situations that may cause anxiety. The questionnaire can be administered verbally for children who are not able to read. Children are asked to indicate for each item whether it makes them feel 'not anxious', 'a little bit anxious' or 'very anxious'.

Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)
Child Behaviour Checklist (CBCL)
Prazo: Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)

The CBCL aims to quantify problem behavior and competences of children and adolescents. This questionnaire with 113 items (0-226, higher scores indicate more emotional and behavioral problems) is used in standard clinical care for routine outcome measuring. The questionnaire is filled out by the parents or caregivers of the child. Parents (both mothers and fathers) indicate on a 3-point scale whether the behavior was present in the last few months. The behavior can be classified according to different scales: Internalizing, Externalizing and other problems.

Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)
Teacher Report Form (TRF)
Prazo: Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)

(C-)TRF is the teacher's version of the CBCL. The TRF has 113 items (0-226, higher scores indicate more emotional and behavioral problems) and is included in standard clinical care for routine outcome measuring. The questionnaire can be filled out by a teacher. The questionnaire gives insight in the child's behavior and competences at school as evaluated by the teacher.

Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)
Parenting burden questionnaire (OBVL)
Prazo: Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)

With the Dutch OBVL, parents are asked to evaluate statements on how they experience their child and rearing, how they relate to their child and how they are feeling. On a 4-point scale parents indicate to what extend they agree with each statement (34 items, 34-136, higher scores indicate less parenting burden). The OBVL consists of 5 subscales: problems in the caregiver-child relationship, problems with upbringing, depressive moods, role restriction and health problems.

Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)
Family Accommodation Scale - Anxiety (FASA)
Prazo: Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)

The questionnaire evaluates the level of family accommodation related to the child's anxiety and the level of distress the child experiences. The FASA consists of 13-questions that are scored on a 5-point Likert scale ranging from "never" to "daily". The first 9 items form the total accommodation scale (0-36, higher scores indicate more family accommodation). The subscale assessing the level of distress (5 items) is scored on a 5-point Likert scale ranging from "no" to "extreme." The FASA is included in standard clinical care for routine outcome measuring.

Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after end of intervention)
Clinical global impression of outcome (CGI)
Prazo: During the intervention phase (up to 1 year), at the end of every therapy session with therapist

The CGI is a 2-item, clinician-rated scale used to assess global illness severity (1-7; higher score indicates more severity), over-all improvement (1-7, higher score indicates less improvement) from the start of treatment.

During the intervention phase (up to 1 year), at the end of every therapy session with therapist
Outcome Rating Scale (ORS)
Prazo: During the intervention phase (up to 1 year), at the end of every therapy session with therapist

The Outcome Rating Scale (ORS) is used to monitor children's, young people and their families' or caregivers' feedback on therapeutic progress. The ORS is a 4-item session-by-session measure designed to assess areas of life functioning known to change as a result of therapeutic intervention. These areas include: personal or symptom distress, interpersonal well-being, social role and overall well-being (for each item 0-10; higher scores indicate better functioning)

During the intervention phase (up to 1 year), at the end of every therapy session with therapist
Therapy evaluation: Visual Facial Anxiety Scale (VFAS)
Prazo: During the intervention (up to 1 year; at the end of each VR session at home and at the end of each therapy session with therapist)

Children are asked to indicate the level of anxiety, using a visual analogue scale, after completing a VR session and after individual therapy. The child can indicate whether they feel none, mild, mild - moderate, moderate, moderate - high or high anxiety.

During the intervention (up to 1 year; at the end of each VR session at home and at the end of each therapy session with therapist)
Qualitative interview child
Prazo: Immediately after intervention (up to 1 year)

A qualitative evaluation will be made after the intervention. During the interview the child will be asked to answer a few short semi-structured questions on their experiences with the VR homework exercises.

Immediately after intervention (up to 1 year)
Monthly VR evaluation
Prazo: During the intervention (once a month, up to 1 year)

The researcher will schedule a 15-minute semi-structured interview to ask parents about their experiences during the VR sessions. The interview contains questions re-garding the practical use of the VR headset, how often parents have practised, the level of anxiety their child experiences while practicing and whether their child likes working with the VR homework exercises. Lastly, parents are asked whether there have been any special events that might have had an influence on the child's SM symptoms or the VR sessions.

During the intervention (once a month, up to 1 year)
Qualitative interview parents
Prazo: Immediately after intervention (up to 1 year), and at follow-up (3 months after the end of the intervention)

A qualitative evaluation will be made after the intervention and after 3 months of follow-up. Both parents or caregivers are asked to share their experiences with the VR homework exercises and their vision on how the use of the VR homework exercises has helped their child to gain the confidence to speak at school.

Immediately after intervention (up to 1 year), and at follow-up (3 months after the end of the intervention)
Qualitative interview therapists
Prazo: Immediately after intervention (up to 1 year)

After the intervention, therapists are asked to share their perspective about the use of the VR homework exercises in addition to the standard treatment. They are asked to identify what factors, such as the relationship with parents or specific characteristics of the child/family contribute or hinder successful usage of the VR homework exercises.

Immediately after intervention (up to 1 year)

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Adult Self Report (ASR)
Prazo: Baseline (2 weeks)

The ASR is a self-report questionnaire for adults (ages 18-59) assessing aspects of adaptive functioning and problems. The questionnaire provides a Total score (123 items, 0-252, higher scores indicate more behavioral and emotional problems) and scores for an Internalizing and Externalizing subscale.

Baseline (2 weeks)
EMBU-P
Prazo: Baseline (2 weeks)

The EMBU-P (with the Swedish name Egna Minnen Beträffende Uppfostran - Parent version) rates the parents' own rearing behavior with their children. Rearing behavior is scored on across 4 dimensions: Rejection, Emotional Warmth, Control Attempts and Favoring Subject. It has 83 items (higher scores per dimension indicate more of that rearing behavior, which can be positive or negative).

Baseline (2 weeks)
Communication - Vineland-3-NL
Prazo: Baseline (2 weeks)

This questionnaire evaluates adaptive behavior on five domains: communication, daily living skills, socialization, motor skills and maladaptive behavior. The questionnaire is suitable for both parents and teachers. Only the domain communication will be assessed as the presence of speech and language problems is often linked to SM.

Baseline (2 weeks)
Immersive Tendencies Questionnaire - Parent report
Prazo: Baseline (2 weeks)

For the purpose of this study, the questions were rephrased to turn the original questionnaire into a parent-report. Parents are asked to evaluate their child's immersive tendencies on a 7-point likert scale, ranging from strongly disagree to strongly agree (10 items, 0-70, higher scores indicate more immersive tendencies).

Baseline (2 weeks)
Intake questionnaire
Prazo: Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after the end of the intervention)

This questionnaire contains questions with regards to background information about the child and his or her family. Questions concerning sex, age, ethnicity, family composition, parental work situation and education level and medical history (including treatment background and earlier diagnoses given to both parents and child) are included.

Baseline (2 weeks), immediately after intervention (up to 1 year) and at follow-up (3 months after the end of the intervention)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de agosto de 2025

Conclusão Primária (Estimado)

1 de abril de 2027

Conclusão do estudo (Estimado)

1 de junho de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

4 de fevereiro de 2025

Enviado pela primeira vez que atendeu aos critérios de CQ

17 de março de 2025

Primeira postagem (Real)

18 de março de 2025

Atualizações de registro de estudo

Última Atualização Postada (Real)

1 de outubro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

28 de setembro de 2026

Última verificação

1 de setembro de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever